Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical timolol for prevention of radiation-induced dermatitis in breast cancer
IRCT20190810044500N11Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of timolol in radiodermatitis, sponsored by Shahid Sadoughi University of Medical Sciences. Started Aug 2020; status: completed.
02
Drugs
timolol
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on IRCT20190810044500N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190810044500N11.